Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-002583-80Phase 4Completed
Phase 4, randomised trial in actinic keratosis (AK) comparing Picato alone with Picato plus clobetasol propionate (2 arms). Primary endpoint: Local skin reactions. Started Sep 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-002583-80.